Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_assertion type Assertion NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_head.
- NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_assertion description "[The A3669G polymorphism, which stabilizes GR? mRNA, had greater frequency in PV (55%; n = 22; P = .0028) and myelofibrosis (35%; n = 20) patients than in NDs (9%; n = 22) or patients with essential thrombocythemia (6%; n = 15).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_provenance.
- NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_assertion evidence source_evidence_literature NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_provenance.
- NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_assertion SIO_000772 21355091 NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_provenance.
- NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_assertion wasDerivedFrom befree-2016 NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_provenance.
- NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_assertion wasGeneratedBy ECO_0000203 NP875521.RAVEK8okArG11TY0tt2xnpGHk9K3r6id7jInFh2qJUICY130_provenance.